Overview
SARS coronavirus (SARS-CoV) is the betacoronavirus that causes Severe Acute Respiratory Syndrome, a contagious respiratory illness responsible for a global outbreak in 2002-2003 that originated in southern China and spread to multiple countries. SARS-CoV is transmitted chiefly through respiratory droplets and close contact, and infection can progress from influenza-like symptoms to severe pneumonia and acute respiratory distress, with substantial mortality. The 2002-2003 epidemic was contained through intensive public-health measures, and no widespread natural transmission of the original SARS-CoV has been documented since. The virus belongs to the same genus as Middle East Respiratory Syndrome coronavirus and SARS-CoV-2, the agent of COVID-19, and the family's capacity for zoonotic emergence and severe respiratory disease has made it a continuing focus of virology and pandemic preparedness. Comparative study of these related coronaviruses addresses their origins, genome and spike-protein evolution, host range, diagnosis, immune responses, and candidate treatments. Research published in this broader coronavirus area reflects these themes, including narrative reviews of the novel coronavirus, molecular evolutionary analyses of SARS-CoV-2 spike-glycoprotein sequences across human and animal coronaviruses, immune-modulatory and other therapeutic approaches, diagnostic RT-PCR assays, cytokine profiling in patients, and discussions of how new coronaviruses arise from longstanding zoonotic reservoirs.
Research published in this journal
12 peer-reviewed articles, ranked by relevance. Each links to its DOI.
Molecular Evolutionary Characteristics of the 2019 Novel Coronavirus (SARS-CoV-2) Contracted by Tunisian Citizens : Comparison and Relationship to Other Human and Animal Coronaviruses Based on Spike Glycoprotein-Coding Gene Sequences Analysis
Animals in the COVID-19 Era: Between Being a source, Victims, or Maybe our Hope to Overcome it!
Reducing COVID-19 Risk through Dietary Supplementation of Plant Mannose Binding Lectins
Cell Therapy as an Alternative approach for COVID-19 Infection Consequences: A Non-Systematic Review
SARS-Corona Virus-2 Origin and Treatment, From Coffee to Coffee: A Double-Edged Sword
Use of Immune Modulator Interferon-Gamma to Support Combating COVID-19 Pandemic
Pyrexia And Liver Injury After A Second SARS-CoV-2 Vaccination: Macrophage Activation Manifested In Liver
Comparative Analysis of Five Commercial RT-PCR Diagnostic Assay for Detection of Covid-19
Cytokine Profiling in COVID-19 Patients in a Tertiary Hospital in Saudi Arabia; the Pre-Storm Phase
COVID-19 Pandemic: The Causative Agent is New, The Problem is Old
Mental Health in The Context of The COVID 19 Pandemic
How this research is being cited
The 12 articles above have been cited 25 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
2025 · Jundishapur Journal of Microbiology
-
2025 · Jundishapur Journal of Microbiology
-
2023 · Revista Brasileira de Farmacognosia
-
2023 · Revista Brasileira de Farmacognosia
-
2023 · Frontiers in Medicine
-
2023 · Frontiers in Medicine
-
2022 · Biomedicine & Pharmacotherapy
-
Cell Therapy as an Alternative approach for COVID-19 Infection Consequences: A Non-Systematic Review2021 · International Journal of Coronaviruses
A sample of recent works citing this journal's research on SARS Coronavirus, linking to each citing work.